Renaissance Technologies (RenTech)'s GMED Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 196,918 shares of Globus Medical, Inc. (GMED) worth $15.56 M, representing 0.02% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in GMED, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2017, adding 608,900 shares. Largest reduction occurred in Q2 2020, reducing 634,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Globus Medical (GMED) Holding Value Over Time
Track share changes against reported price movement
Quarterly Globus Medical (GMED) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +196,918 | New Buy | 196,918 | $79.01 |
| Q4 2025 | -243,918 | Sold Out | 0 | $0.00 |
| Q3 2025 | +138,500 | Add 131.38% | 243,918 | $57.27 |
| Q2 2025 | -71,500 | Reduce 40.41% | 105,418 | $59.02 |
| Q1 2025 | +176,918 | New Buy | 176,918 | $73.20 |
| Q4 2023 | -158,518 | Sold Out | 0 | $0.00 |
| Q3 2023 | +158,518 | New Buy | 158,518 | $49.65 |
| Q3 2022 | -54,700 | Sold Out | 0 | $0.00 |
| Q2 2022 | -10,100 | Reduce 15.59% | 54,700 | $56.14 |
| Q1 2022 | +17,700 | Add 37.58% | 64,800 | $73.78 |
| Q4 2021 | -133,546 | Reduce 73.93% | 47,100 | $72.21 |
| Q3 2021 | +37,546 | Add 26.24% | 180,646 | $76.62 |
| Q2 2021 | -25,600 | Reduce 15.17% | 143,100 | $77.53 |
| Q1 2021 | +39,200 | Add 30.27% | 168,700 | $61.67 |
| Q4 2020 | -14,014 | Reduce 9.76% | 129,500 | $65.22 |
| Q3 2020 | -566,800 | Reduce 79.80% | 143,514 | $49.52 |
| Q2 2020 | -634,400 | Reduce 47.18% | 710,314 | $47.71 |
| Q1 2020 | +266,700 | Add 24.74% | 1.34 M | $42.53 |
| Q4 2019 | -167,386 | Reduce 13.44% | 1.08 M | $58.88 |
| Q3 2019 | -19,200 | Reduce 1.52% | 1.25 M | $51.12 |
| Q2 2019 | -95,200 | Reduce 7.00% | 1.26 M | $42.30 |
| Q1 2019 | +137,400 | Add 11.24% | 1.36 M | $49.41 |
| Q4 2018 | +331,965 | Add 37.28% | 1.22 M | $43.28 |
| Q3 2018 | +35,535 | Add 4.16% | 890,435 | $56.76 |
| Q2 2018 | +351,100 | Add 69.69% | 854,900 | $50.46 |
| Q1 2018 | +82,600 | Add 19.61% | 503,800 | $49.82 |
| Q4 2017 | -258,100 | Reduce 37.99% | 421,200 | $41.10 |
| Q3 2017 | +608,900 | Add 864.91% | 679,300 | $29.72 |
| Q2 2017 | +70,400 | New Buy | 70,400 | $33.15 |
| Q3 2016 | -104,700 | Sold Out | 0 | $0.00 |
| Q2 2016 | -242,000 | Reduce 69.80% | 104,700 | $23.83 |
| Q1 2016 | +346,700 | New Buy | 346,700 | $23.75 |
| Q4 2015 | -143,945 | Sold Out | 0 | $0.00 |
| Q3 2015 | +143,945 | New Buy | 143,945 | $20.66 |
| Q2 2015 | -98,300 | Sold Out | 0 | $0.00 |
| Q1 2015 | -151,800 | Reduce 60.70% | 98,300 | $25.24 |
| Q4 2014 | -602,400 | Reduce 70.66% | 250,100 | $23.77 |
| Q3 2014 | +66,100 | Add 8.41% | 852,500 | $19.67 |
| Q2 2014 | +605,287 | Add 334.20% | 786,400 | $23.92 |
| Q1 2014 | -92,487 | Reduce 33.80% | 181,113 | $26.59 |
| Q4 2013 | +273,600 | New Buy | 273,600 | $20.18 |
Renaissance Technologies (RenTech)'s Globus Medical Investment FAQs
Renaissance Technologies (RenTech) first purchased Globus Medical, Inc. (GMED) in Q4 2013, acquiring 273,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Globus Medical, Inc. (GMED) for 41 quarters since Q4 2013.
Renaissance Technologies (RenTech)'s largest addition to Globus Medical, Inc. (GMED) was in Q3 2017, adding 679,300 shares worth $20.19 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 196,918 shares of Globus Medical, Inc. (GMED), valued at approximately $15.56 M.
As of the Q2 2026 filing, Globus Medical, Inc. (GMED) represents approximately 0.02% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Globus Medical, Inc. (GMED) was 1,359,800 shares, as reported at the end of Q1 2019.